Modern Healthcare Technology Holdings Limited (0919) AI Stock Analysis

• Market Cap: HK$75.07M
• Dividend Yield: N/A
• Average Volume (3M): 241.87K
• Price to Earnings (P/E): 24.4
• Beta (1Y): >-0.01
• Revenue Growth: -0.31%
• EPS Growth: 47.17%
• Country: HK
• Employees: 850
• Sector: Consumer Cyclical
• Sector Strength: 84
• Industry: Personal Products & Services
• EPS (TTM): 0.01
• Shares Outstanding: 904,483,950
• 10 Day Avg. Volume: 193,200
• 30 Day Avg. Volume: 241,866
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 46 Neutral
• Price Target: HK$0.00 ▼(-100.00% Downside)

The overall stock score is primarily impacted by weak financial performance, with declining revenue and profitability. Technical analysis indicates bearish momentum, further weighing on the score. Valuation metrics are unfavorable, with a negative P/E ratio and no dividend yield, limiting the stock's attractiveness.

Modern Healthcare Technology Holdings Limited Business Overview & Revenue Model

Company Description

Modern Healthcare Technology Holdings Limited, an investment holding company, provides beauty and wellness services in Hong Kong, the People's Republic of China, Singapore, and Australia. The company operates in two segments, Beauty and Wellness Services, and Skincare and Wellness Products. It offers beauty and facial services; aesthetics services, such as skincare treatment, professional consultation, skin care and anti-ageing, and referral services on plastic reconstruction; slimming services, including weight management programs; and spa and massage services comprising resplendent bathroom furnishings and a hydrotherapeutic pool, as well as foot spa, foot treatment, and foot massage services. The company also sells skincare and wellness products under the be, FERRECARE, p.e.n, Y.U.E., Advanced Natural, Malu Wilz, Byotea, Care Plus, Cellnoc, Mu-lan Spa, Cellnoc, Veribe, Castille, Dr Plus, Eclat du teint, and Natural Care brand names. In addition, it provides franchise and trademark services in relation to beautification and gymnastic services; advertising services; maid agency services; and management services, as well as food and beverage services. As of March 31, 2022, the company had 30 service centers in Hong Kong; 3 service centers in Mainland China; and 7 service centers in Singapore, as well as 8 be Beauty Shop outlets. Modern Healthcare Technology Holdings Limited is headquartered in Kowloon Bay, Hong Kong.

How the Company Makes Money

The company generates revenue through multiple streams, primarily by selling its healthcare technology products and services to hospitals, clinics, and other healthcare facilities. This includes software licensing fees, subscription services for ongoing support, and maintenance contracts. Additionally, Modern Healthcare Technology Holdings Limited may engage in partnerships with other technology firms and healthcare organizations, leading to collaborative projects that can enhance its service offerings and increase revenue. The company may also benefit from government contracts or grants aimed at improving healthcare technology infrastructure, further contributing to its financial growth.

Modern Healthcare Technology Holdings Limited Financial Statement Overview

Summary

The company faces challenges with declining revenue and profitability, as reflected in negative net profit margins and return on equity. However, improvements in cash flow generation and leverage management provide a positive outlook for future financial stability.

Income Statement

The company has experienced declining revenue growth, with a negative growth rate in the most recent year. Gross profit margins remain healthy, but net profit margins are negative, indicating profitability challenges. EBIT and EBITDA margins have also declined significantly, suggesting operational inefficiencies.

Balance Sheet

The debt-to-equity ratio has improved, indicating better leverage management. However, the return on equity is negative, reflecting ongoing profitability issues. The equity ratio remains stable, suggesting a solid asset base relative to equity.

Cash Flow

The company has shown strong free cash flow growth, indicating improved cash generation capabilities. The operating cash flow to net income ratio is positive, suggesting efficient cash conversion, although the free cash flow to net income ratio indicates room for improvement.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	469.33M	453.27M	454.71M	406.33M	355.59M	431.45M
Gross Profit	128.49M	165.26M	166.96M	394.72M	341.52M	417.67M
EBITDA	79.80M	77.11M	95.68M	92.32M	43.96M	255.36M
Net Income	2.93M	-5.07M	-9.57M	-20.61M	-68.81M	125.72M
Balance Sheet
Total Assets	585.70M	564.46M	611.04M	561.35M	570.96M	669.04M
Cash, Cash Equivalents and Short-Term Investments	190.92M	236.67M	193.66M	177.53M	127.53M	234.34M
Total Debt	89.23M	68.65M	106.57M	40.11M	65.01M	115.07M
Total Liabilities	405.37M	373.26M	416.65M	357.47M	347.75M	376.15M
Stockholders Equity	175.09M	185.85M	189.33M	199.77M	219.58M	289.37M
Cash Flow
Free Cash Flow	45.57M	134.94M	64.08M	125.52M	-29.55M	121.64M
Operating Cash Flow	69.33M	151.09M	78.66M	139.82M	51.31M	123.88M
Investing Cash Flow	-17.44M	-50.50M	8.16M	-13.17M	-79.96M	-2.85M
Financing Cash Flow	-69.01M	-66.24M	-70.60M	-77.31M	-78.46M	-77.89M

Modern Healthcare Technology Holdings Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.08
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0919, the sentiment is Negative. The current price of 0.08 is below the 20-day moving average (MA) of 0.09, below the 50-day MA of 0.09, and below the 200-day MA of 0.09, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 35.85 is Neutral, neither overbought nor oversold. The STOCH value of 30.09 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0919.

Modern Healthcare Technology Holdings Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
8603	72 Outperform	HK$1.60B	34.97	43.10%	―	45.40%	12.38%
0922	67 Neutral	HK$339.87M	6.65	5.45%	7.19%	-16.88%	-11.54%
6966	64 Neutral	HK$485.00M	-66.44	4.31%	1.13%	-38.66%	-161.86%
1827	59 Neutral	HK$400.00M	37.74	7.18%	―	-18.43%	―
0919	46 Neutral	HK$75.07M	24.38	-2.50%	―	-0.31%	47.17%
8296	44 Neutral	HK$36.38M	-7.00	-7.05%	―	15.60%	62.35%
Sector *	61 Neutral	$18.38B	12.79	-2.54%	3.03%	1.52%	-15.83%

Modern Healthcare Technology Holdings Limited Corporate Events

Modern Healthcare Technology Secures Unanimous Shareholder Support at AGM

Modern Healthcare Technology Holdings Limited announced that all resolutions proposed at their Annual General Meeting on August 28, 2025, were unanimously approved by shareholders through a poll. The resolutions included adopting financial statements, re-electing directors, authorizing directors’ remuneration, re-appointing KPMG as auditors, and granting mandates to issue and repurchase shares. This unanimous approval reflects strong shareholder support and positions the company for continued operational stability and strategic flexibility in the market.

Modern Healthcare Technology Holdings Announces 2025 AGM Agenda

Modern Healthcare Technology Holdings Limited has announced its upcoming Annual General Meeting (AGM) scheduled for August 28, 2025, in Hong Kong. Key agenda items include the adoption of financial statements, re-election of directors, re-appointment of KPMG as auditors, and authorization for the board to manage share allotments. These resolutions, if passed, will influence the company’s governance and financial strategies, potentially impacting its market position and shareholder value.

Modern Healthcare Technology Updates Nomination Committee Terms

Modern Healthcare Technology Holdings Limited has updated the terms of reference for its Nomination Committee, which is responsible for advising the board on its composition and succession planning. This update aims to ensure a diverse and effective board structure, with a requirement for gender diversity among its members, potentially impacting the company’s governance and strategic direction.

Modern Healthcare Technology Holdings Limited Reports Annual Results for FY2025

Modern Healthcare Technology Holdings Limited announced its annual results for the fiscal year ending March 31, 2025. The company reported a slight decrease in revenue to HK$453,274,000 from the previous year, with a net loss of HK$4,771,000, though showing an improvement from the previous year’s loss. The results reflect challenges in managing costs and market conditions, impacting profitability. Despite these challenges, the company managed to reduce its loss, indicating potential stabilization in its operations.